PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITION FOR DIMINISHING ENHANCED PRESSURE OF THE PULMONARY CIRCULATION

The present invention is concerned with the use of a compound of formula (I) wherein -W- is selected from where a is 0 or 1, U is hydrogen or halogen and Z is -V(CH2)b-CO2H where b is an integer of from 1 to 3 and V is oxygen or methylene; X is hydrogen, methyl, halogen, cyano, or -C IDENTICAL CH; Y...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WHITTLE,BRENDAN JOSEPH RICHARD,GB, TADEPALLI,ANJANEYULU SEETHARM,US, KLEIN,KENNETH BRUCE,US, LONG,WALKER ANDERSON,US, CROW,JAMES WALKER,US
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator WHITTLE,BRENDAN JOSEPH RICHARD,GB
TADEPALLI,ANJANEYULU SEETHARM,US
KLEIN,KENNETH BRUCE,US
LONG,WALKER ANDERSON,US
CROW,JAMES WALKER,US
description The present invention is concerned with the use of a compound of formula (I) wherein -W- is selected from where a is 0 or 1, U is hydrogen or halogen and Z is -V(CH2)b-CO2H where b is an integer of from 1 to 3 and V is oxygen or methylene; X is hydrogen, methyl, halogen, cyano, or -C IDENTICAL CH; Y is oxygen, methylene, - N=, or -N(Ar)- where Ar is an optionally substituted phenyl group; R is -(CH2)5R where R is hydrogen or methyl, or R is cyclohexyl, or R is -CH(CH3)CH2C IDENTICAL CCH3; R1 is hydrogen or methyl; and the dotted lines represent independently optional double bonds; and physiologically acceptable salts and acid derivatives thereof, in the manufacture of a medicament for the prophylaxis or treatment of pulmonary hypertension and in the manufacture of a diagnostic aid for identifying PPH (primary pulmonary hypertensive) patients having active pulmonary vasoconstriction. Medicaments and diagnostic aids obtained by the use of the invention which may be administered when primary or secondary pulmonary hypertension is indicated are also within the scope of the invention.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HU207220B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HU207220B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HU207220B3</originalsourceid><addsrcrecordid>eNqFjLsKwkAQRdNYiPoLMj8ghFhYr5OJO5DdWfZRpApB1kpMIP4_JmJvdU9xzt0Wo_OCFAI04mHhOiHbGzitvFFIKTKqFlCMk8CRxX7Fmg1bDnpVyWplkeqlXn6SJ5AGoiZwqTVile8A2WNq1Zrvi81jeM758NtdcWwooj7laezzPA33_MrvXqeqvFRVeT3_FT6vxTbv</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITION FOR DIMINISHING ENHANCED PRESSURE OF THE PULMONARY CIRCULATION</title><source>esp@cenet</source><creator>WHITTLE,BRENDAN JOSEPH RICHARD,GB ; TADEPALLI,ANJANEYULU SEETHARM,US ; KLEIN,KENNETH BRUCE,US ; LONG,WALKER ANDERSON,US ; CROW,JAMES WALKER,US</creator><creatorcontrib>WHITTLE,BRENDAN JOSEPH RICHARD,GB ; TADEPALLI,ANJANEYULU SEETHARM,US ; KLEIN,KENNETH BRUCE,US ; LONG,WALKER ANDERSON,US ; CROW,JAMES WALKER,US</creatorcontrib><description>The present invention is concerned with the use of a compound of formula (I) wherein -W- is selected from where a is 0 or 1, U is hydrogen or halogen and Z is -V(CH2)b-CO2H where b is an integer of from 1 to 3 and V is oxygen or methylene; X is hydrogen, methyl, halogen, cyano, or -C IDENTICAL CH; Y is oxygen, methylene, - N=, or -N(Ar)- where Ar is an optionally substituted phenyl group; R is -(CH2)5R where R is hydrogen or methyl, or R is cyclohexyl, or R is -CH(CH3)CH2C IDENTICAL CCH3; R1 is hydrogen or methyl; and the dotted lines represent independently optional double bonds; and physiologically acceptable salts and acid derivatives thereof, in the manufacture of a medicament for the prophylaxis or treatment of pulmonary hypertension and in the manufacture of a diagnostic aid for identifying PPH (primary pulmonary hypertensive) patients having active pulmonary vasoconstriction. Medicaments and diagnostic aids obtained by the use of the invention which may be administered when primary or secondary pulmonary hypertension is indicated are also within the scope of the invention.</description><edition>5</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1993</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19930329&amp;DB=EPODOC&amp;CC=HU&amp;NR=207220B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19930329&amp;DB=EPODOC&amp;CC=HU&amp;NR=207220B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WHITTLE,BRENDAN JOSEPH RICHARD,GB</creatorcontrib><creatorcontrib>TADEPALLI,ANJANEYULU SEETHARM,US</creatorcontrib><creatorcontrib>KLEIN,KENNETH BRUCE,US</creatorcontrib><creatorcontrib>LONG,WALKER ANDERSON,US</creatorcontrib><creatorcontrib>CROW,JAMES WALKER,US</creatorcontrib><title>PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITION FOR DIMINISHING ENHANCED PRESSURE OF THE PULMONARY CIRCULATION</title><description>The present invention is concerned with the use of a compound of formula (I) wherein -W- is selected from where a is 0 or 1, U is hydrogen or halogen and Z is -V(CH2)b-CO2H where b is an integer of from 1 to 3 and V is oxygen or methylene; X is hydrogen, methyl, halogen, cyano, or -C IDENTICAL CH; Y is oxygen, methylene, - N=, or -N(Ar)- where Ar is an optionally substituted phenyl group; R is -(CH2)5R where R is hydrogen or methyl, or R is cyclohexyl, or R is -CH(CH3)CH2C IDENTICAL CCH3; R1 is hydrogen or methyl; and the dotted lines represent independently optional double bonds; and physiologically acceptable salts and acid derivatives thereof, in the manufacture of a medicament for the prophylaxis or treatment of pulmonary hypertension and in the manufacture of a diagnostic aid for identifying PPH (primary pulmonary hypertensive) patients having active pulmonary vasoconstriction. Medicaments and diagnostic aids obtained by the use of the invention which may be administered when primary or secondary pulmonary hypertension is indicated are also within the scope of the invention.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1993</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjLsKwkAQRdNYiPoLMj8ghFhYr5OJO5DdWfZRpApB1kpMIP4_JmJvdU9xzt0Wo_OCFAI04mHhOiHbGzitvFFIKTKqFlCMk8CRxX7Fmg1bDnpVyWplkeqlXn6SJ5AGoiZwqTVile8A2WNq1Zrvi81jeM758NtdcWwooj7laezzPA33_MrvXqeqvFRVeT3_FT6vxTbv</recordid><startdate>19930329</startdate><enddate>19930329</enddate><creator>WHITTLE,BRENDAN JOSEPH RICHARD,GB</creator><creator>TADEPALLI,ANJANEYULU SEETHARM,US</creator><creator>KLEIN,KENNETH BRUCE,US</creator><creator>LONG,WALKER ANDERSON,US</creator><creator>CROW,JAMES WALKER,US</creator><scope>EVB</scope></search><sort><creationdate>19930329</creationdate><title>PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITION FOR DIMINISHING ENHANCED PRESSURE OF THE PULMONARY CIRCULATION</title><author>WHITTLE,BRENDAN JOSEPH RICHARD,GB ; TADEPALLI,ANJANEYULU SEETHARM,US ; KLEIN,KENNETH BRUCE,US ; LONG,WALKER ANDERSON,US ; CROW,JAMES WALKER,US</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HU207220B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1993</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WHITTLE,BRENDAN JOSEPH RICHARD,GB</creatorcontrib><creatorcontrib>TADEPALLI,ANJANEYULU SEETHARM,US</creatorcontrib><creatorcontrib>KLEIN,KENNETH BRUCE,US</creatorcontrib><creatorcontrib>LONG,WALKER ANDERSON,US</creatorcontrib><creatorcontrib>CROW,JAMES WALKER,US</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WHITTLE,BRENDAN JOSEPH RICHARD,GB</au><au>TADEPALLI,ANJANEYULU SEETHARM,US</au><au>KLEIN,KENNETH BRUCE,US</au><au>LONG,WALKER ANDERSON,US</au><au>CROW,JAMES WALKER,US</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITION FOR DIMINISHING ENHANCED PRESSURE OF THE PULMONARY CIRCULATION</title><date>1993-03-29</date><risdate>1993</risdate><abstract>The present invention is concerned with the use of a compound of formula (I) wherein -W- is selected from where a is 0 or 1, U is hydrogen or halogen and Z is -V(CH2)b-CO2H where b is an integer of from 1 to 3 and V is oxygen or methylene; X is hydrogen, methyl, halogen, cyano, or -C IDENTICAL CH; Y is oxygen, methylene, - N=, or -N(Ar)- where Ar is an optionally substituted phenyl group; R is -(CH2)5R where R is hydrogen or methyl, or R is cyclohexyl, or R is -CH(CH3)CH2C IDENTICAL CCH3; R1 is hydrogen or methyl; and the dotted lines represent independently optional double bonds; and physiologically acceptable salts and acid derivatives thereof, in the manufacture of a medicament for the prophylaxis or treatment of pulmonary hypertension and in the manufacture of a diagnostic aid for identifying PPH (primary pulmonary hypertensive) patients having active pulmonary vasoconstriction. Medicaments and diagnostic aids obtained by the use of the invention which may be administered when primary or secondary pulmonary hypertension is indicated are also within the scope of the invention.</abstract><edition>5</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_HU207220B
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITION FOR DIMINISHING ENHANCED PRESSURE OF THE PULMONARY CIRCULATION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T04%3A13%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WHITTLE,BRENDAN%20JOSEPH%20RICHARD,GB&rft.date=1993-03-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHU207220B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true